¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Control Monitoring System Misc"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 4
¿µ¹® autonomic nervous system ÇÑ±Û ÀÚÀ²½Å°æ°è
¼³¸í   
  »ç¶÷ÀÇ ÀÇÁö¿Í °ü°è¾øÀÌ, Ä§À» È긮°Å³ª ¼ÒÈ­¿îµ¿ µî°ú °°Àº ½º½º·Î Á¶Á¤ÀÌ µÇ¾î ¿òÁ÷À̴ ½Å°æ°èÀ̸砿©±â¿¡´Â ´ÙÀ½°ú °°Àº µÎ °¡Áö°¡ ÀÖ´Ù.
  
  1.±³°¨½Å°æ°è(sympathetic nervous system)-»ç¶÷ÀÌ À§Çè»óÅ¿¡ À̸£·¶À» °æ¿ì¿¡ ÈïºÐÀÌ µÇ´Â ÀÚÀ²½Å°æ°è. ÁɹڼöÀÇ Áõ°¡, ¼ÒÈ­±â ¿îµ¿ÀÇ °¨¼Ò µîÀÇ ÀÏÀÌ À̰÷À» ÅëÇØ¼­ ÀϾ´Ù. ±³°¨½Å°æÀÌ ÈïºÐµÇ¸é ±³°¨½Å°æÀÇ ¸»´Ü¿¡¼­ epinephrine, norepinephrine µîÀÇ ¹°ÁúÀÌ ºÐºñµÇ°í À̰͵鿡 ÀÇÇØ¼­ ¸»ÃÊÀå±â°¡ º¯È­¸¦ ÀÏÀ¸Å²´Ù. ÇÏÁö¸¸ Àå±â¿¡ µû¶ó¼­ epinephrineÀ̳ª norepinephrineÀÇ ¼ö¿ëü¸¦ °¡Áö°í À־ ¿©·¯ °¡Áö ´Ù¸¥ Àå±âÀÇ ¹ÝÀÀÀ» º¼ ¼ö°¡ ÀÖ´Ù. ¼ö¿ëü´Â ´ÙÀ½°ú °°´Ù.
  
    -¾ËÆÄ¼ö¿ëü(alpha-receptor): ¸»ÃÊÇ÷°üÀÇ ¼öÃà, ±â°üÁöÀÇ ¼öÃà, µ¿°øÀÇ ±ÙÀ°ÀÇ ¼öÃà
  
    -º£Å¸1¼ö¿ëü(beta 1-receptor): ½ÉÀå¿¡ Á¸ÀçÇϴ ¼ö¿ëü, ½ÉÀåÀ» »¡¸® ¶Ù°ÔÇϴ ¿ªÇÒÀ» ÇÑ´Ù.
  
    -º£Å¸2¼ö¿ëü(beta 2-receptor): Ç÷°üÀÇ ÀÌ¿Ï, ±â°üÁöÀÇ ÀÌ¿Ï, Áï °¢ Àå±âµéÀº ±× Àå±â°¡ °¡Áö°í Àִ ±³°¨½Å°æÀÇ ¼ö¿ëü¿¡ µû¶ó ±³°¨½Å°æÀÇ ÈïºÐ(±³°¨½Å°æ ¸»´Ü¿¡¼­ÀÇ epinephrineÀÇ ºÐºñ)¿¡ ´ëÇÑ ¹ÝÀÀÀÌ ´Þ¶óÁø´Ù(¿¹-±³°¨½Å°æÀÌ ÈïºÐ½Ã¿¡ beta 1-¼ö¿ëü¸¦ °¡Áö°í Àִ ½ÉÀåÀº »¡¸® ¶Ù°Ô µÈ´Ù. ±³°¨½Å°æ ÈïºÐ½Ã¿¡ µ¿°øÀÇ ±ÙÀ°ÀÌ ¼öÃàÇØ¼­ µ¿°øÀÇ Å©±â°¡ Ä¿Áø´Ù)
  
  2.ºÎ±³°¨½Å°æ°è(parasympathetic nervous system)-±³°¨½Å°æ°ú ¹Ý´ë·Î ÀÛ¿ëÇÑ´Ù. Áï »ç¶÷ÀÌ Á¹¸®°Å³ª ½¯ °æ¿ì¿¡ ÈïºÐÇÑ´Ù. ºÎ±³°¨½Å°æÀÌ ÈïºÐÇÒ ¶§¿¡´Â ½Å°æÀÇ ¸»´Ü¿¡¼­ ¾Æ¼¼Ä¥Äݸ°ÀÇ ºÐºñ°¡ ÀϾ°í À̰ÍÀ¸·Î ÀÎÇØ¼­ °¢ Àå±âÀÇ º¯È­°¡ ÀϾ´Ù.
¿µ¹® TNM staging system ÇÑ±Û Á¾¾çº´±âºÐ·ù°èÅë
¼³¸í   
  Á¾¾çÀÇ º´±â(stage)¸¦ °áÁ¤Çϴ ÇÑ ¹æ¹ý.
  
  T´Â Tumor(Á¾¾ç)¸¦ ¶æÇϸ砿ø¹ßº´ÅÍÀÇ Å©±â, ÁÖÀ§Á¶Á÷À¸·ÎÀǠħÀ±Á¤µµ µî¿¡ µû¶ó T1, T2, T3, T4(¼ýÀÚ°¡ ³ôÀ» ¼ö·Ï ÁÖÀ§·Î Ä§À±ÀÌ ¸¹´Ù) µîÀ¸·Î ³ª´«´Ù.
  
  NÀº Node(¸²ÇÁÀý)¸¦ ¶æÇϸç Ä§¹üµÈ ¸²ÇÁÀýÀÇ °¹¼ö, Å©±â, À§Ä¡ µî¿¡ µû¶ó N1, N2, N3 µîÀ¸·Î ³ª´«´Ù.
  
  MÀº Metastasis(ÀüÀÌ)¸¦ ¶æÇϸ砿ø°ÝÀüÀÌÀÇ À¯¹«¿¡ µû¶ó M0, M1 µîÀ¸·Î ³ª´«´Ù.
  
  ÀÌ»óÀÇ ¹æ¹ýÀ¸·Î T, N, MÀÌ °áÁ¤µÇ¸é À̵éÀ» Á¶ÇÕÇÏ¿© ÃÖÁ¾ÀûÀΠº´±â¸¦ °áÁ¤ÇÑ´Ù. ÀÌ·¸°Ô °áÁ¤µÈ º´±â´Â Ä¡·á ¹æÄ§ °áÁ¤°ú ¿¹ÈÄ ÆÇ´Ü¿¡ ¸Å¿ì Áß¿äÇÏ´Ù.
¿µ¹® central nervous system(CNS) ÇÑ±Û ÁßÃ߽Űæ°è
¼³¸í   
  ½Å°æ°è´Â ÁßÃ߽Űæ°è¿Í ¸»ÃʽŰæ°è·Î ºÐ·ùÇÒ ¼ö°¡ ÀÖ´Ù. ÁßÃ߽Űæ°è¶õ ³ú¿Í Ã´¼ö·Î ±¸¼ºµÇ¾î Àִ ½Å°æ°è¸¦ À̸£´Â ¸»ÀÌ´Ù. ¸»ÃʽŰæ°è¶õ ÀÌ ÀÌ¿ÜÀÇ ¸ðµç ½Å°æ°è¸¦ À̸£´Â ¸»ÀÌ´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • hospital control
    º´¿ø´ëÁ¶±º
  • hospital infection control
    º´¿ø°¨¿°°ü¸®
  • inventory control
    Àç°í°ü¸®
  • impulse control disorder
    Ãæµ¿Á¶ÀýÀå¾Ö
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • injury control
    »óÇØ°ü¸®
  • insect control
    °ïÃæ±¸Á¦
  • laboratory infection control
    °Ë»ç½Ç°¨¿°°ü¸®
  • leprosy control program
    ³ªº´°ü¸®»ç¾÷
  • local control
    ±¹¼ÒÁ¦¾î
  • matched control
    ¦ÁöÀº´ëÁ¶±º
  • membrane control protein
    ¸·Á¶Àý´Ü¹éÁú
  • neighborhood control
    ÀÌ¿ô´ëÁ¶±º
  • nosocomial infection control
    º´¿ø³»°¨¿°°ü¸®
  • pain control
    ÅëÁõÁ¶Àý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • hospital control
    º´¿ø´ëÁ¶±º
  • hospital infection control
    º´¿ø°¨¿°°ü¸®
  • injury control
    »óÇØ°ü¸®
  • insect control
    °ïÃæ±¸Á¦
  • inventory control
    Àç°í°ü¸®
  • laboratory infection control
    °Ë»ç½Ç°¨¿°°ü¸®
  • local control
    ±¹¼ÒÁ¦¾î
  • matched control
    ¦ÁöÀº´ëÁ¶±º
  • neighborhood control
    ÀÌ¿ô´ëÁ¶±º
  • nosocomial infection control
    ¿ø³»°¨¿°°ü¸®
  • pain control
    ÅëÁõÁ¦¾î
  • quality control
    Á¤µµ°ü¸®, ǰÁú°ü¸®, Áú°ü¸®
  • reflex control
    ¹Ý»çÁ¶Àý
  • relaxed control
    ÇØÀ̺¹Á¦Á¶Àý
  • safety control
    ¾ÈÀü°ü¸®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Duffy system
    ´õÇǰè.
  • Female reproductive system
    ¿©¼º(Ò³àõ)»ý½Ä±â°ü(ßæãÖÐïί)
  • Fibrinolytic system
    ¼¶À¯¼Ò¿ëÇØ°è(¡­Ìõ)
  • Fisher-Race system
    Çǽ¬-·¹À̽º ½Ã½ºÅÛ
  • Gastrointestinal system
    À§Àå°ü°è(êÖíóηͧ)
  • General anesthesia, reticular activating system and.
    Àü½Å¸¶Ãë(îïãóئö­), ¸Á»óüȰ¼ºÈ­°è(ØÑßÒô÷üÀàõûùͧ)
  • Glycogen-lactic acid system
    ±Û¸®ÄÚ°Õ-¶ôÆ®»ê°è
  • Haversian system
    »À ´ÜÀ§<°ñ¿ø>, ÇϹö½º °èÅë(¡­Í§÷Ö).
  • Haversian system
    »À´ÜÀ§<°ñ¿ø>, ÇϹö½º°è Åë(¡­Í§÷Ö).
  • Haversian system
    ÇϹö½º°è
  • Hypothalamic-hypophysial portal system
    ½Ã»óÇϺÎ-Çϼöü ¹®¸Æ°è(ãÊßÉù»Ý» ù»á÷ô÷ Ú¦ØæÍ§)
  • Immune system
    ¸é¿ªÃ¼°è(Øóæ¹ô÷ͧ)
  • International System of Unit
    ±¹Á¦´ÜÀ§°è
  • Jackson-Rees anesthetic circuit system
    Àè½¼-¸® ¸¶ÃëÀåÄ¡
  • Kell blood group system
    ÄÌÇ÷¾×Çü±º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • control
    ´ëÁ¶(¾à).
  • control
    ´ëÁ¶(ËÀÌ¡), Á¶Àý(Ì¡Ëø), Á¦¾î(Ì¡Ëâ), °ü¸®(Ë´Ëö), ±ÔÁ¦(˻̡), ¹æÁ¦( ËÑÌ¡) ÊÙÀ¯Çع°ÁúÀÇÊÙ.
  • control equipment
    Á¦¾îÀåÄ¡(Ì¡ËâËö̬).
  • control equipment
    Á¦¾îÀåÄ¡(ð¤åÙíûöÇ).
  • control equipment
    Á¦¾îÀåÄ¡(Á¦¾îÀåÄ¡).
  • control experiment
    ´ëÁ¶½ÇÇè(ÓßðÎãùúÐ).
  • control experiment
    ´ëÁ¶½ÇÇè(ËÀÌ¡ËàÌ´).
  • control gene
    Á¦¾îÀ¯ÀüÀÚ(ð¤åÙë¶îîí­).
  • control group
    ´ëÁ¶±º(ÓßðÎÏÛ)
  • control group
    ´ëÁ¶±º(ËÀ̡˴).
  • control handle
    Á¶Àý¹½__
  • control hole
    (À¯µ¹µ¿)°üÂû¿ë ¼Ò°ø(êáÔÍ÷ÓδóÌéÄá³Íî).
  • control level
    °ü¸®¼öÁØ(Ë´ËöËàÌ¡).
  • control limit
    °ü¸®ÇѰè(Ë´Ëö̰˭).
  • control mechanism
    Á¶Àý±âÀü
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • fatty acid synthetase system
    Áö¹æ»ê ÇÕ¼º È¿¼Ò(ò·Û¸ß«ùêà÷ý£áÈ)½Ã½ºÅÛ
  • genetic system
    À¯Àü(ë¶îî) ½Ã½ºÅÛ
  • host-guest system
    ÁÖ-°´(ñ«-ËÔ) ½Ã½ºÅÛ
  • hydrogen transport system
    ¼ö¼Ò ¼ö¼Û(â©áÈâÃáê) ½Ã½ºÅÛ
  • inducible system
    À¯µµ°¡´É(ë¯ÓôʦÒö) ½Ã½ºÅÛ
  • intrinsic system
    ³»ÀÎ(Ò®ì×) ½Ã½ºÅÛ
  • isolated system
    °Ý¸®(̰×î)½Ã½ºÅÛ
  • Kovats retention index system
    ÄÚ¹ÙÆ® ü·ù(ôò׺) Áö¼ö(ò¦â¦)½Ã½ºÅÛ
  • K system
    K ½Ã½ºÅÛ
  • leiotonin system
    ¶óÀÌ¿ÀÅä´Ñ ½Ã½ºÅÛ
  • MN blood group system
    MN½Ä(ãÒ)Ç÷¾×Çü(úìäûúþ)
  • model system
    ¸ðµ¨½Ã½ºÅÛ
  • multienzyme system
    ´ÙÈ¿¼Ò(Òýý£áÈ)½Ã½ºÅÛ
  • multisubstrate enzyme system
    ´Ù±âÁúÈ¿¼Ò(ÒýѨòõý£áÈ) ½Ã½ºÅÛ
  • open-circuit system
    °³¹æÈ¸·Î(ËÒÛ¯üÞÖØ) ½Ã½ºÅÛ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
PCM patient care manager or management; patient classification system; primary cutaneous melanoma; proce...
AFP Alpha(¥á) Feto-Protein [HP 1826, 1858, 1859, 2265]
  ; Oncofetal Antigens
 &nbs...
SMBG Self Monitoring of Blood Glucose
AEM Academic Emergency Medicine [journal]; analytical electron microscopy; ambulatory electrocardiograph...
APM Academy of Parapsychology and Medicine; Academy of Physical Medicine; Academy of Psychosomatic Medic...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
MONICA MONItoring Trends and Determinants in CArdiovascular Disease
MONICA MONItoring of trends and determinants in CArdiovascular disease
MRM Multiple reaction monitoring
PEM Prescription-Event Monitoring
SIM Selected Ion Monitoring
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • autologous blood recovery system
    ÀÚ°¡ Ç÷¾× ȸº¹ ÀåÄ¡
  • autonomic nervous system
    ÀÚÀ² ½Å°æ°è, ÀÚÀ² ½Å°æ°èÅë
    ºÒ¼öÀǼºÀ¸·Î »ýü ±â´ÉÀ» Á¶Àý. ½Åü Àü¹Ý¿¡ ÀÖ´Â ÆòȰ±Ù°ú ¼±Á¶Á÷¿¡ °ü¿©ÇÏ´Â ¸»ÃʽŰæ°èÀÇ ÀϺκÐÀÌ´Ù. À̰ÍÀº ¿îµ¿
  • autonomic nervous system arousal
    ÀÚÀ² ½Å°æ°è °¢¼º
  • bicarbonate buffer system
    Áßź»ê¿° ¿ÏÃæ°è
  • biliary system
    ´ã³¶°è
  • biomedical classification system
    »ýÀÇÇÐÀû ºÐ·ù ü°è
  • breathing system
    È£Èí ÀåÄ¡
  • buffer system
    ¿ÏÃæ°è
  • central nerve system mechanism
    ÁßÃß ½Å°æ°è ±âÀü
  • central nervous system mechanism
    ÁßÃß ½Å°æ°è ±âÀü
  • central piping system
    Áß¾Ó ¹è°ü ½Ã¼³
  • centrencephalic system
    Á᫐ ³ú°è
  • cerebrospinal system
    ³ú ô¼ö°è
  • combined system disease
    º¹ÇÕ °èÅë Áúȯ
  • concise enamel bond system
    ´Ü¼ø ¹ý¶ûÁú °áÇÕ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
control element Generic term for a region of DNA, such as a promoter or enhancer adjacent to (or within) a gene that allows the regulation of gene expression by the binding of transcription factors.
(18 Nov 1997)
control experiment An experiment used to check another, to verify the result, or to demonstrate what would have occurred had the factor under study been omitted.
See: control, control animal.
(05 Mar 2000)
control gene See: operator gene, regulator gene.
(05 Mar 2000)
control group A group of subjects participating in the same experiment as another group of subjects, but which is not exposed to the variable under investigation.
See: experimental group.
(05 Mar 2000)
control limit A regulatory value applied to the airborne concentration in the workplace of a potentially poisonous substance which is judged to be reasonably practicable for the whole spectrum of work activities and which must not normally be exceeded.
(09 Oct 1997)
Control of Communicable Diseases in Man The internationally recognised authoritative manual now in the 15th (1990) edition, published by the American Public Health Association.
(05 Mar 2000)
control plot A plot in which no vegetation will be cut and natural succession will occur. A control plot serves as a baseline to compare other treatments (Early, Mid and Late Seral).
(05 Dec 1998)
control release suture Eyeless suture with thread attached to needle such that the two separate when tension is applied to the thread.
(05 Mar 2000)
control syringe A type of Luer-Lok syringe with thumb and finger rings attached to the proximal end of the barrel and to the tip of the plunger, allowing operation of the syringe with one hand.
Synonym: ring syringe.
(05 Mar 2000)
poison control centres Facilities which provide information concerning poisons and treatment of poisoning in emergencies.
(12 Dec 1998)
cost control The containment, regulation, or restraint of costs. Costs are said to be contained when the value of resources committed to an activity is not considered excessive. This determination is frequently subjective and dependent upon the specific geographic area of the activity being measured.
(12 Dec 1998)
population control Includes mechanisms or programs which control the numbers of individuals in a population of humans or animals.
(12 Dec 1998)
positive control Mechanism for gene regulation that requires that a regulatory protein must interact with some region of the gene before transcription can be activated.
(18 Nov 1997)
self-control 1. Self-regulation of one's behaviour in accordance with personal beliefs, goals, attitudes and societal expectations.
2. Use by an individual of active coping strategies to deal with problem situations, in contrast to passive conditioning strategies which do things to the individual and require no action by the person.
(05 Mar 2000)
social control The influence on the behaviour of a person exerted by other persons or by society as a whole; e.g., through appropriate social norms, ostracism, or the criminal law.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • radio-control
    ¹«¼± Á¶Á¾ÇÏ´Ù
  • remote control
    ¿ø°Ý Á¶ÀÛ(Á¦¾î);¸®¸ðÆ® ÄÜÆ®·Ñ
  • ripple control
    ¸®Çà ÄÁÆ®·Ñ(Àü·Â¼ö¿äÀÇ ÇÇÅ© ŸÀÓ¿¡ Àü·Âȸ»ç°¡ ¼ö¿ä °¡Á¤ÀÇ ¿Â¼ö±â¸¦ ÀÚµ¿ÀûÀ¸·Î ²ô´Â ½Ã½ºÅÛ)
  • thought control
    »ç»óÅëÁ¦
  • traffic control
    ±³Åë Á¤¸®
  • system
    Á¶Á÷,°èÅë,¹æ½Ä
  • Bertillon system
    º£¸£Æ¼¿ë½Ä ¹üÀνĺ°¹ý(Áö¹®À» Áß½Ã)
  • CAPTAIN System
    ĸƾ½Ã½ºÅÛ(°¡Á¤ÀÇ À¯¼± ÅÚ·¹ºñÀü¿¡ÀÇ Á¤º¸ Á¦°ø ½Ã½ºÃÀ,»óÇ¥¸í)
  • Continental System
    ´ë·úºÀ¼â(1806³â NapoleonÀÇ ¿µ±¹¿¡ ´ëÇÑ)
  • Copernican system
    ÄÚÆä¸£´ÏÄí½º¼³(ü°è);(žçÁ߽ɼ³,Áöµ¿¼³)
  • Dewey classification system
    µµ¼­ÀÇ µàÀÌ 10Áø ºÐ·ù¹ý
  • Dolby system
    µ¹ºñ¹æ½Ä(³ìÀ½ Å×ÀÌÇÁÀÇ ÀâÀ½À» ÁÙÀÌ´Â ¹æ¹ý)
  • Doppler Lidar System
    µµÇ÷¯ È¿°ú¸¦ ÀÌ¿ëÇÑ ±¤ÇÐ½Ä ¼Óµµ°è
  • European Monetary System
    À¯·´ ÅëÈ­ Á¦µµ
  • Federal Reserve System
    ¿¬¹æÁغñÁ¦µµ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á